化学療法誘発性脱毛症（CIA）治療デバイスの市場規模、シェア、動向分析レポート：製品別、販売形態別、適応症別、最終用途別、地域別、セグメント別予測、2024年～2030年

化学療法誘発性脱毛症（CIA）治療デバイス市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界の化学療法誘発性脱毛症（CIA）治療デバイスの市場規模は2030年までに1億7,470万米ドルに達すると予測され、2024年から2030年までのCAGRは14.6%で成長すると予測されています。

市場を牽引する主な要因は、化学療法の採用増加、技術の進歩、認知度の向上と採用、政府の取り組みです。2024年、米国がん協会は、米国における子宮がんの新規症例数を約67,880人と予測し、約13,250人の女性がこの病気で死亡すると予測しています。この症例数の多さは、化学療法誘発性脱毛症（CIA）治療装置を含む、効果的な治療オプションの継続的な必要性を浮き彫りにしています。このような患者の多くが化学療法を受けるため、脱毛に対処するソリューションに対する需要が増加し、女性のがん治療の旅をサポートするCIA治療機器の重要性が強調されています。

化学療法誘発性脱毛症（CIA）治療デバイスの進歩が市場成長の原動力となっています。2024年3月に発表されたNCBIの論文によると、化学療法誘発性脱毛症（CIA）を軽減する非薬理学的アプローチであるコールドキャッピングは、治療中の毛髪を保存する可能性があるとして認知されつつあります。様々な患者層における手動式コールドキャッピングシステムの実際の有効性と忍容性を検討した研究によると、コールドキャッピングを開始した100人の患者のうち95％がそのプロセスを完了しました。毛髪維持率の中央値は75%で、92.1%の患者が50%以上の毛髪を維持するという良好な結果を得たと報告されています。

化学療法誘発性脱毛症（CIA）治療デバイス市場レポートハイライト：

• 継続的な製品の進歩、主要企業によるイニシアチブの拡大、がん罹患率の増加により、手動冷却システム分野が2023年に52.7%の最大収益シェアで市場をリードしました。
• 販売形態別では、レンタル販売分野が2023年に80.9%の最大売上シェアで市場をリードしました。頭皮冷却システムに対する患者の意識の高まりが、レンタルオプションの需要を高めています。化学療法による脱毛を緩和しようとする人が増えるにつれ、ヘルスケアプロバイダーはレンタルプログラムを含むサービスを拡大し、利用しやすさを高めています。
• 適応症別では、乳がん分野が2023年に66.9%の最大売上シェアで市場を牽引しました。乳がんの罹患率の上昇、技術の進歩、意識の高まりが市場成長の原動力となっています。
• 最終用途別では、病院セグメントが2023年に44.8%の最大収益シェアで市場をリードしました。病院は、化学療法に関連する脱毛を緩和する実証済みの方法を患者に提供するため、これらのCIA装置を腫瘍科に組み込んでいます。
• 北米は2023年に52.8%の最大収益シェアで市場を独占しました。がん患者の増加、製品の発売、規制当局の承認、高度なヘルスケアインフラが、北米のCIA治療機器需要を牽引しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の化学療法誘発性脱毛症（CIA）治療デバイス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 化学療法誘発性脱毛症（CIA）治療デバイス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 化学療法誘発性脱毛症（CIA）治療デバイス市場：製品別推定・動向分析

• 化学療法誘発性脱毛症（CIA）治療デバイス市場：製品ダッシュボード
• 化学療法誘発性脱毛症（CIA）治療デバイス市場：製品変動分析
• 化学療法誘発性脱毛症（CIA）治療デバイス市場規模と予測および動向分析、製品別、2018～2030年
• 手動冷却システム
• 自動冷却システム

第5章 化学療法誘発性脱毛症（CIA）治療デバイス市場： 販売形態別推定・動向分析

• 化学療法誘発性脱毛症（CIA）治療デバイス市場：販売モダリティダッシュボード
• 化学療法誘発性脱毛症（CIA）治療デバイス市場：販売形態変動分析
• 化学療法誘発性脱毛症（CIA）治療デバイス市場規模と予測および動向分析、販売形態別、2018～2030年
• レンタル販売
• 直接販売

第6章 化学療法誘発性脱毛症（CIA）治療デバイス市場：適応症別推定・動向分析

• 化学療法誘発性脱毛症（CIA）治療デバイス市場：適応症ダッシュボード
• 化学療法誘発性脱毛症（CIA）治療デバイス市場：適応症変動分析
• 化学療法誘発性脱毛症（CIA）治療デバイス市場規模と予測および動向分析、適応症別、2018～2030年
• 乳がん
• 前立腺がん
• 卵巣がん
• 子宮がん
• その他

第7章 化学療法誘発性脱毛症（CIA）治療デバイス市場：最終用途別推定・動向分析

• 化学療法誘発性脱毛症（CIA）治療デバイス市場：最終用途ダッシュボード
• 化学療法誘発性脱毛症（CIA）治療デバイス市場：最終用途変動分析
• 化学療法誘発性脱毛症（CIA）治療デバイス市場規模と予測および動向分析、最終用途別、2018～2030年
• 病院
• がんセンター
• 外来診療所

第8章 化学療法誘発性脱毛症（CIA）治療デバイス市場： 国、製品、適応症、販売形態、最終用途別の地域別推定・動向分析

• 世界の化学療法誘発性脱毛症（CIA）治療デバイス市場：地域ダッシュボード
• 市場規模と予測動向分析、2018年から2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 主要メーカーによる最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2023年
  • Dignitana
  • Paxman
  • Penguin Cold Caps
  • Chemotherapy Cold Caps, Inc.
  • Aspen Systems, LLC's
  • Cooler Heads Care, Inc.
  • Arctic Cold Caps, LLC
  • Stemtech Medical Devices
  • Polar Cold Caps LLC

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 Global Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 4 Global Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 5 Global Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 6 Global Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030
• Table 7 Global Chemotherapy induced alopecia (CIA) treatment device market, by region, 2018 - 2030 (USD Million)
• Table 8 North America Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
• Table 9 North America Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 10 North America Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 11 North America Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 12 North America Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 13 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 14 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 15 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 16 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 17 Canada Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 18 Canada Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 19 Canada Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 20 Canada Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 21 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 22 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 23 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 24 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 25 Europe Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
• Table 26 Europe Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 27 Europe Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 28 Europe Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 29 Europe Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 30 UK Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 31 UK Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 32 UK Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 33 UK Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 34 Germany Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 35 Germany Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 36 Germany Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 37 Germany Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 38 France Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 39 France Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 40 France Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 41 France Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 42 Italy Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 43 Italy Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 44 Italy Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 45 Italy Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 46 Spain Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 47 Spain Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 48 Spain Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 49 Spain Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 50 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 51 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 52 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 53 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 54 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 55 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 56 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 57 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 58 Norway Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 59 Norway Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 60 Norway Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 61 Norway Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 67 Japan Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 68 Japan Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 69 Japan Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 70 Japan Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 71 China Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 72 China Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 73 China Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 74 China Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 75 India Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 76 India Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 77 India Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 78 India Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 79 Australia Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
• Table 80 Australia Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 81 Australia Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 82 Australia Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 83 Australia Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 84 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 85 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 86 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 87 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 88 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 89 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 90 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 91 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 92 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
• Table 93 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 94 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 95 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 96 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 97 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 98 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 99 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 100 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 101 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 102 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 103 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 104 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 105 MEA Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
• Table 106 MEA Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 107 MEA Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 108 MEA Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 109 MEA Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 110 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 111 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 112 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 113 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 117 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 118 UAE Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 119 UAE Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 120 UAE Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 121 UAE Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 122 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
• Table 123 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
• Table 124 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
• Table 125 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
• Table 126 Participant's overview
• Table 127 Financial performance
• Table 128 Key companies undergoing expansions
• Table 129 Key companies undergoing acquisitions
• Table 130 Key companies undergoing collaborations
• Table 131 Key companies launching new products
• Table 132 Key companies undergoing partnerships
• Table 133 Key companies undertaking other strategies

List of Figures

• Fig. 1 Chemotherapy induced alopecia (CIA) treatment device market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Chemotherapy induced alopecia (CIA) treatment device market revenues, 2023 (USD Millions)
• Fig. 9 Market driver relevance analysis (Current & future impact)
• Fig. 10 Market restraint relevance analysis (Current & future impact)
• Fig. 11 Porter's five forces analysis
• Fig. 12 PESTLE analysis
• Fig. 13 Chemotherapy induced alopecia (CIA) treatment device market Product outlook:
• Fig. 14 Chemotherapy induced alopecia (CIA) treatment device market: Product movement analysis
• Fig. 15 Segment dashboard
• Fig. 16 Global manual cooling systems market, 2018 - 2030 (USD Million)
• Fig. 17 Global automated cooling systems market, 2018 - 2030 (USD Million)
• Fig. 18 Chemotherapy induced alopecia (CIA) treatment device market Sales modality outlook:
• Fig. 19 Chemotherapy induced alopecia (CIA) treatment device market: Sales modality movement analysis
• Fig. 20 Global rental sales market, 2018 - 2030 (USD Million)
• Fig. 21 Global direct sales market, 2018 - 2030 (USD Million)
• Fig. 22 Chemotherapy induced alopecia (CIA) treatment device market Indication outlook:
• Fig. 23 Chemotherapy induced alopecia (CIA) treatment device market: Indication movement analysis
• Fig. 24 Global breast cancer market, 2018 - 2030 (USD Million)
• Fig. 25 Global prostate cancer market, 2018 - 2030 (USD Million)
• Fig. 26 Global ovarian cancer market, 2018 - 2030 (USD Million)
• Fig. 27 Global uterine cancer market, 2018 - 2030 (USD Million)
• Fig. 28 Global others market, 2018 - 2030 (USD Million)
• Fig. 29 Chemotherapy induced alopecia (CIA) treatment device market End Use outlook:
• Fig. 30 Chemotherapy induced alopecia (CIA) treatment device market: End Use movement analysis
• Fig. 31 Global hospitals market, 2018 - 2030 (USD Million)
• Fig. 32 Global cancer centers market, 2018 - 2030 (USD Million)
• Fig. 33 Global outpatient clinics market, 2018 - 2030 (USD Million)
• Fig. 34 Regional market place: Key takeaways
• Fig. 35 North America Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 36 U.S. Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 37 Canada Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 38 Mexico Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 39 Europe Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 40 Germany Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 41 UK Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 42 France Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 43 Italy Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 44 Spain Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 45 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 46 Japan Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 47 China Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 48 India Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 49 Australia Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 50 Latin America Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 51 Brazil Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 52 MEA Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 53 South Africa Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 54 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
• Fig. 55 Market Participant Categorization
• Fig. 56 Strategy mapping

Chemotherapy-induced Alopecia Treatment Device Market Growth & Trends:

The global chemotherapy induced alopecia treatment device market size is anticipated to reach USD 174.7 million by 2030 and is projected to grow at a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are increasing chemotherapy adoption, technological advancements, growing awareness & adoption, and government initiatives. In 2024, the American Cancer Society forecasts around 67,880 new cases of uterine cancer in the United States, with approximately 13,250 women expected to die from the disease. This significant number of cases highlights an ongoing need for effective treatment options, including chemotherapy-induced alopecia (CIA) treatment devices. As many of these patients undergo chemotherapy, there will be an increased demand for solutions that address hair loss, underscoring the importance of CIA treatment devices in supporting women through their cancer treatment journey

Advancements in chemotherapy-induced alopecia (CIA) treatment devices are driving the market growth. According to NCBI article published in March 2024, Cold capping, a non-pharmacologic approach to reducing chemotherapy-induced alopecia (CIA), is gaining recognition for its potential to preserve hair during treatment. A study reviewing the real-world effectiveness and tolerability of a manual cold capping system across diverse patient demographics found that 95% of the 100 patients who initiated cold capping completed the process. The median hair retention was reported at 75%, with 92.1% of patients achieving favorable results, defined as retaining 50% or more of their hair.

Chemotherapy-induced Alopecia Treatment Device Market Report Highlights:

• The manual cooling systems segment led the market with the largest revenue share of 52.7% in 2023, due to ongoing product advancements, growing initiatives by key companies, and increasing cancer prevalence
• Based on sales modality, the rental sales segment led the market with the largest revenue share of 80.9% in 2023. Growing patient awareness of scalp cooling systems has increased demand for rental options. As more individuals seek to mitigate chemotherapy-induced hair loss, healthcare providers are expanding their services to include rental programs, enhancing accessibility
• Based on indication, the breast cancer segment led the market with the largest revenue share of 66.9% in 2023. Rising incidence of breast cancer, technological advancement, and growing awareness drive the market growth
• Based on end use, the hospital segment led the market with the largest revenue share at 44.8% in 2023. Hospitals are integrating these CIA devices into their oncology departments to offer patients a proven method for mitigating chemotherapy-related hair loss
• North America dominated the market with the largest revenue share of 52.8% in 2023. Rising cancer cases, product launches, regulatory approvals, and advanced healthcare infrastructure drive North America's demand for CIA treatment devices

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Sales Modality
  • 1.2.3. Indication
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecast timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity price analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Segment
  • 2.2.2. Sales Modality Segment
  • 2.2.3. Indication Segment
  • 2.2.4. End Use Segment
  • 2.2.5. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Chemotherapy Induced Alopecia (CIA) Treatment Device Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of cancer
    • 3.2.1.2. Increasing prevalence of chemotherapy-induced alopecia
    • 3.2.1.3. Technological advancements
    • 3.2.1.4. Growing Awareness and Adoption
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Low product awareness
    • 3.2.2.2. Limited number of manufacturers
• 3.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Estimates & Trend Analysis

• 4.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Dashboard
• 4.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Movement Analysis
• 4.3. Chemotherapy Induced Alopecia (CIA) Treatment Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Manual Cooling Systems
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Automated Cooling Systems
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Estimates & Trend Analysis

• 5.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Dashboard
• 5.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Movement Analysis
• 5.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by Sales Modality, 2018 to 2030 (USD Million)
• 5.4. Rental Sales
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Direct Sales
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Estimates & Trend Analysis

• 6.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Dashboard
• 6.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Movement Analysis
• 6.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 6.4. Breast Cancer
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Prostate Cancer
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Ovarian Cancer
  • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.7. Uterine Cancer
  • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: End Use Estimates & Trend Analysis

• 7.1. Chemotherapy Induced Alopecia (CIA) Treatment Device market: End Use Dashboard
• 7.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: End Use Movement Analysis
• 7.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.5. Cancer Centers
  • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.6. Outpatient Clinics
  • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Regional Estimates & Trend Analysis by Country, Product, Indication, Sales Modality, & End Use

• 8.1. Global Chemotherapy induced alopecia (CIA) treatment device market: Regional Dashboard
• 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Regulatory framework/ reimbursement structure
    • 8.3.4.3. Competitive scenario
    • 8.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.8. Norway
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.9. Denmark
    • 8.4.9.1. Key country dynamics
    • 8.4.9.2. Regulatory framework/ reimbursement structure
    • 8.4.9.3. Competitive scenario
    • 8.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.3. Japan
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework/ reimbursement structure
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7.3. South Africa
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2023
  • 9.3.4. Dignitana
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Paxman
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Penguin Cold Caps
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Chemotherapy Cold Caps, Inc.
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Aspen Systems, LLC's
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Cooler Heads Care, Inc.
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Arctic Cold Caps, LLC
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Stemtech Medical Devices
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Polar Cold Caps LLC
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives